Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
The value of specialty pharmaceuticals - a systematic review.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Tysabri prescribing information
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.
Autoimmune myelopathies.
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
Natural History of Multiple Sclerosis Symptoms
Treatment selection and experience in multiple sclerosis: survey of neurologists.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Medicare Part D payments for neurologist-prescribed drugs.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
Pages
« first
‹ previous
…
148
149
150
151
152
153
154
155
156
…
next ›
last »